Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat
American Journal of Cardiovascular Drugs · 2025-05 · 25 (3) · 329-336
DOI: 10.1007/s40256-024-00713-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Cardiovascular Drugs, online erschienen am 31.12.2024. Verfasst von Jessica Huston und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, 580 W. 8th Street, Jacksonville, FL, USA. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Cytochrome P-450 CYP11B2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Patients with hypertension are at an increased risk of cardiovascular disease and death. Resistant hypertension, or hypertension that is unsuccessfully treated with multiple antihypertensive medications, further exacerbates the complications and negative outcomes for patients. A new pathway, via aldosterone synthesis inhibition, is currently being studied as a method to reduce blood pressure values in patients who are currently taking other antihypertensive medications. This review presents and discusses the current pharmacokinetic, pharmacodynamic, and clinical and scientific evidence pertaining to baxdrostat, a novel aldosterone synthase inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, 580 W. 8th Street, Jacksonville, FL, USA.
- East Coast Institute for Research, 3550 University Blvd S #101, Jacksonville, FL, USA.
- Lake Erie College of Osteopathic Medicine - Bradenton Campus, 5000 Lakewood Ranch Blvd., Bradenton, Florida, USA.
- Georgia Mountain Endocrinology, 120 Oakside Ct, Canton, GA, USA.
- Ashchi Heart and Vascular Center, 3900 University Blvd S, Jacksonville, FL, USA.
- Northeast Florida Endocrine and Diabetes Associates, 3550 University Blvd S #301, Jacksonville, FL, USA.
Zitieren
APA
Huston, J., Orey, D., Kumar, A., Ashchi, A., Ashchi, A., Berner, J., Alkhouri, Y., Sutton, D., Deeb, W., Bisharat, M., & Goldfaden, R. F. (2025). Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat. American Journal of Cardiovascular Drugs, 25(3), 329-336. https://doi.org/10.1007/s40256-024-00713-w
Vancouver
Huston J, Orey D, Kumar A, Ashchi A, Ashchi A, Berner J, et al. Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat. American Journal of Cardiovascular Drugs. 2025;25(3):329-336. doi:10.1007/s40256-024-00713-w
BibTeX
@article{Huston2025,
author = {Huston, Jessica and Orey, Dontia and Kumar, Ashish and Ashchi, Andrew and Ashchi, Andrea and Berner, Jason and Alkhouri, Yazan and Sutton, David and Deeb, Wasim and Bisharat, Mohannad and Goldfaden, Rebecca F},
title = {Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat},
journal = {American Journal of Cardiovascular Drugs},
year = {2025},
volume = {25},
number = {3},
pages = {329--336},
doi = {10.1007/s40256-024-00713-w}
}
EUVIMED